Jose Ignacio Mayordomo MD

Physician

1635 Aurora CtAurora, CO 80045
Phone+1 720-848-0300
Fax+1 720-848-1774

Dr. Mayordomo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mayordomo's full profile Already have an account?

Education & Training

University of Zaragoza School of MedicinePh.D., Medicine, 1991
Universidad de Zaragoza Faculty of MedicineClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CO State Medical License 2012 - 2023

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Star Award Denver Health Hospital, 2014

Clinical Trials

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
TERMINATED
PHASE3

Publications & Presentations

PubMed

9 citations
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J Brenner
Clinical Cancer Research. 2023-12-15
16 citations
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump
NPJ Breast Cancer. 2023-05-20
150 citations
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and...
Funda Meric-Bernstam, Muralidhar Beeram, Erika Hamilton, Do-Youn Oh, Diana L Hanna
The Lancet. Oncology. 2022-12-01

Journal Articles

Phase III Multicenter Clinical Trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
Ibrahim N, Miles D, Tres A, Roche H, Guillem V, Martin M, Perren T, Cameron D, Glaspy J, Dodwell D, Parker J, Mayordomo J, and the Theratope Study Group, Oncologist, 1/1/2011
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients
Carrato Mena A, Paz-Ares Rodriguez L, Rodriguez Lescure A, Casas Fernandez de Tejerina AM, Diaz Rubio Garcia E, Perez Segura P, Constenla Figueiras M, Garcia Carbonero..., Clinical and Translational Oncology, 1/1/2009
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain
Mayordomo JI, Lopez A, Vinolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sanchez J; ENIA Study Group, Curr Med Res Opin, 1/1/2009